(Q38401463)

English

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

scientific article published on 21 August 2012

Statements

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer (English)
Julie Lee
Brian Lasonde
William P Tew
Afra Yehwalashet
Kian Behbakht
Jill Grothusen
Gini Fleming
Nita K Lee
Jamie Arnott
Mark R Bray
Graham Fletcher
Richard D Brokx
Vincent Castonguay
Helen Mackay
Carolyn F Sidor
Amit M Oza
21 August 2012
121-131

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit